Huihua Xiong Selected Research

Huihua Xiong Research Topics

Disease

36	Neoplasms (Cancer) 01/2024 - 02/2007
10	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2006
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2023 - 01/2017
6	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 04/2015
5	Stomach Neoplasms (Stomach Cancer) 12/2023 - 02/2011
3	Hypoxia (Hypoxemia) 01/2022 - 04/2015
3	Radiation Pneumonitis 01/2017 - 03/2013
3	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2013
2	Triple Negative Breast Neoplasms 01/2024 - 01/2023
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2017
2	Disease Progression 01/2023 - 04/2012
2	Adenocarcinoma of Lung 11/2022 - 01/2022
2	Sarcopenia 01/2021 - 11/2020
2	Colorectal Neoplasms (Colorectal Cancer) 06/2018 - 12/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2014 - 03/2013
1	Adenocarcinoma 12/2023
1	Thrombocytopenia (Thrombopenia) 10/2023
1	Hemorrhage 10/2023
1	Glioma (Gliomas) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Primitive Neuroectodermal Tumors (PNET) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Malnutrition (Nutritional Deficiencies) 11/2020
1	Sarcoma (Soft Tissue Sarcoma) 07/2020
1	Necrosis 07/2019
1	Nasopharyngeal Carcinoma 01/2019

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2015
7	Proteins (Proteins, Gene)FDA Link 06/2023 - 02/2007
4	Long Noncoding RNAIBA 11/2022 - 06/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2009
4	Small Interfering RNA (siRNA)IBA 07/2019 - 01/2006
3	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2021
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2018
3	Messenger RNA (mRNA)IBA 01/2023 - 02/2007
2	Oxygen (Dioxygen)IBA 01/2024 - 02/2011
2	human ERBB2 proteinIBA 01/2023 - 08/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2017
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 10/2021
2	MicroRNAs (MicroRNA)IBA 01/2023 - 06/2015
2	CarbonIBA 01/2023 - 01/2022
2	6-methyladenineIBA 01/2022 - 01/2021
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2018 - 08/2011
2	Matrix Metalloproteinases (MMPs)IBA 07/2015 - 04/2015
2	Polysaccharides (Glycans)IBA 07/2015 - 04/2015
2	SurvivinIBA 02/2007 - 01/2006
1	Capsaicin (Zostrix)FDA Link 01/2024
1	Hydroxyl RadicalIBA 01/2024
1	ElementsIBA 01/2024
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2024
1	Liposomes (Liposome)IBA 01/2024
1	Peroxidase (Myeloperoxidase)IBA 01/2024
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 01/2024
1	PalladiumIBA 01/2024
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2024
1	130-nm albumin-bound paclitaxelIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	toripalimabIBA 01/2024
1	Thrombopoietin (c-mpl Ligand)IBA 10/2023
1	hetrombopagIBA 10/2023
1	serum P-component (CIt)IBA 10/2023
1	Hormones (Hormone)IBA 01/2023
1	Letrozole (Femara)FDA LinkGeneric 01/2023
1	Circular RNAIBA 01/2023
1	ProdrugsIBA 01/2023
1	PlatinumIBA 01/2023
1	pyrotinibIBA 01/2023
1	Serine (L-Serine)FDA Link 01/2023
1	B7-H1 AntigenIBA 12/2022
1	TantalumIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2021
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	N-methyladenosineIBA 01/2021
1	Cystatin CIBA 01/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021
1	CreatinineIBA 01/2021
1	RNA Helicases (RNA Helicase)IBA 01/2021
1	Celecoxib (Celebrex)FDA Link 01/2021
1	Indicators and Reagents (Reagents)IBA 11/2020
1	Complement System Proteins (Complement)IBA 07/2020
1	Keratin-18 (Keratin 18)IBA 07/2019
1	PhosphoproteinsIBA 08/2018
1	ThrombospondinsIBA 01/2018

Therapy/Procedure

9	Therapeutics 12/2023 - 01/2021
7	Radiotherapy 01/2022 - 03/2013
6	Drug Therapy (Chemotherapy) 01/2024 - 01/2018
2	Precision Medicine 12/2023 - 01/2022
2	Immunotherapy 11/2022 - 01/2022
1	Radioimmunotherapy 01/2024
1	Drug Tapering 10/2023
1	Molecular Targeted Therapy 06/2023
1	Chemoradiotherapy 02/2023
1	Adjuvant Chemotherapy 02/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Microspheres (Microsphere) 01/2018